Disclosed herein are methods for selectively treating atopic dermatitis (AD) in a subject having skin excoriations, pharmaceutical compositions for use in the treatment of atopic dermatitis in a subject having skin excoriations, uses of nemolizumab or an equivalent thereof in the manufacture of a medicament for the treatment of atopic dermatitis in a subject having skin excoriations, and methods of identifying a subject having atopic dermatitis that is likely to respond to nemolizumab treatment or an equivalent thereof.本文揭示用於選擇性治療患有皮膚表皮脫落之個體之異位性皮膚炎(atopic dermatitis；AD)之方法、用於治療患有皮膚表皮脫落之個體之異位性皮膚炎的醫藥組合物、尼立珠單抗(nemolizumab)或其等效物在製造用以治療患有皮膚表皮脫落之個體之異位性皮膚炎之藥物中的用途以及鑑別可能對尼立珠單抗治療或其等效物起反應之患有異位性皮膚炎之個體的方法。
